Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib vs Placebo in Advanced/Metastatic Renal Cell Carcinoma
NCT00334282Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 2006
- Primary completion
- May 2008
- Modality
- Small Molecules
- Countries
- 25
01
Overview
A Phase 3 trial of pazopanib in renal cell carcinoma (RCC), sponsored by GSK. Started Apr 2006; status: completed.
02
Drugs
pazopanib
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00334282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00334282.